{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:49:25Z","timestamp":1792684165975,"version":"4.5.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1038\/s41569-024-01059-1","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T16:19:45Z","timestamp":1719505185000},"page":"597-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transcatheter treatment of pure aortic regurgitation"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-5437","authenticated-orcid":false,"given":"Marco","family":"Barbanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Laterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0195-668X(03)00201-X","volume":"24","author":"B Iung","year":"2003","unstructured":"Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231\u20131243 (2003).","journal-title":"Eur. Heart J."},{"key":"1059_CR2","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","volume":"76","author":"JD Carroll","year":"2020","unstructured":"Carroll, J. D. et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 76, 2492\u20132516 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1059_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1253\/circj.CJ-17-0672","volume":"82","author":"A Yousef","year":"2018","unstructured":"Yousef, A. et al. Transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation \u2014 a systematic review. Circ. J. 82, 895\u2013902 (2018).","journal-title":"Circ. J."},{"key":"1059_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.jacc.2013.01.018","volume":"61","author":"DA Roy","year":"2013","unstructured":"Roy, D. A. et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J. Am. Coll. Cardiol. 61, 1577\u20131584 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.jacc.2017.10.006","volume":"70","author":"SH Yoon","year":"2017","unstructured":"Yoon, S. H. et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J. Am. Coll. Cardiol. 70, 2752\u20132763 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1059_CR6","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.jcin.2023.07.026","volume":"16","author":"E Poletti","year":"2023","unstructured":"Poletti, E. et al. Transcatheter aortic valve replacement for pure native aortic valve regurgitation: the PANTHEON international project. JACC Cardiovasc. Interv. 16, 1974\u20131985 (2023).","journal-title":"JACC Cardiovasc. Interv."},{"key":"1059_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12872-023-03667-0","volume":"24","author":"MH Elkasaby","year":"2024","unstructured":"Elkasaby, M. H. et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for pure aortic regurgitation: a systematic review and meta-analysis of 33,484 patients. BMC Cardiovasc. Disord. 24, 65\u201372 (2024).","journal-title":"BMC Cardiovasc. Disord."},{"key":"1059_CR8","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.athoracsur.2022.09.016","volume":"115","author":"A Mentias","year":"2023","unstructured":"Mentias, A. et al. Transcatheter vs surgical aortic valve replacement in pure native aortic regurgitation. Ann. Thorac. Surg. 115, 870\u2013876 (2023).","journal-title":"Ann. Thorac. Surg."},{"key":"1059_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(23)02806-4","volume":"403","author":"TP Vahl","year":"2024","unstructured":"Vahl, T. P. et al. Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study. Lancet 403, 1451\u20131459 (2024).","journal-title":"Lancet"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01059-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01059-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T13:09:53Z","timestamp":1723640993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01059-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1038\/s41569-024-01059-1","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"27 June 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B. is consultant for Boston Scientific, Edwards Lifesciences and Medtronic. F.M. declares grant or research institutional support from Abbott, Biotronik, Boston Scientific, Edwards Lifesciences, Medtronic, NVT, Terumo and Venus; has received consulting fees and honoraria (both personal and institutional) from Abbott, Cardiovalve, Edwards Lifesciences, Medtronic, Mtex, Occlufit, Simulands, Squadra, Valgen, Venus and Xeltis; has received royalty income from Edwards Lifesciences; and is shareholder (including share options) of 4Tech, Magenta and Transseptalsolutions. G.L. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}